Delhi High Court has banned the sale of generic medicines. Actually, the court has banned generic cancer medicines. After all, why has this decision been taken? Let us tell you the reason behind it. The court has banned the generic version of the medicine of 6 Indian pharmaceutical companies namely Natco Pharma, Hetero, BDR Pharma, Shilpa Medicare, Alkem and Laurus Labs. This decision was taken because this pharmaceutical company was violating the rules of drug patent. The patent for Ibrutinib is held by Pharmaceuticals, a co-company of American company AbbVie.…
Read MoreSale Of Generic Versions Of Cancer Drug Stops As Delhi HC Prohibits Patent Infringement
